Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment

DNA Repair

Volumn 32, Issue , 2015, Pages 180-189

  Scanlon, Susan E ^a   Glazer, Peter M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damage response; DNA repair; Gene regulation; Gene silencing; Genetic instability; Hypoxia; Post translational modifications; Replication stress; Tumor microenvironment

Indexed keywords

ANOXIA; ARTICLE; CANCER CELL; CANCER GROWTH; CELL HYPOXIA; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; EPIGENETICS; EXCISION REPAIR; GENE; GENE SILENCING; GENOMIC INSTABILITY; HUMAN; MISMATCH REPAIR; MLH1 GENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY;

ATM PROTEIN; ATM PROTEIN, HUMAN; ATR PROTEIN, HUMAN; DNA;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL HYPOXIA; DNA BREAKS, DOUBLE-STRANDED; DNA MISMATCH REPAIR; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84938484319     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2015.04.030     Document Type: Article

References (114)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 2004, 14:198-206.
3. Multhoff G., Radons J., Vaupel P. Critical role of aberrant angiogenesis in the development of tumor hypoxia and associated radioresistance. Cancers 2014, 6:813-828.
4. Vaupel P., Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metast. Rev. 2007, 26:225-239.
5. Jubb A.M., Buffa F.M., Harris A.L. Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis. J. Cell. Mol. Med. 2010, 14:18-29.
6. Vaupel P., Mayer A., Hockel M. Tumor hypoxia and malignant progression. Methods Enzymol. 2004, 381:335-354.
7. Vaupel P., Mayer A. Hypoxia in tumors: pathogenesis-related classification, characterization of hypoxia subtypes, and associated biological and clinical implications. Adv. Exp. Med. Biol. 2014, 812:19-24.
8. Chang J., Erler J. Hypoxia-mediated metastasis. Adv. Exp. Med. Biol. 2014, 772:55-81.
9. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 2004, 5:343-354.
10. Webb J.D., Coleman M.L., Pugh C.W. Hypoxia, hypoxia-inducible factors (HIF) HIF hydroxylases and oxygen sensing. Cell. Mol. Life Sci.: CMLS 2009, 66:3539-3554.
11. Wouters B.G., Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 2008, 8:851-864.
12. Taylor C.T., Cummins E.P. The role of NF-kappaB in hypoxia-induced gene expression. Ann. N.Y. Acad. Sci. 2009, 1177:178-184.
13. Bindra R.S., Glazer P.M. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat. Res. 2005, 569:75-85.
14. Paquette B., Little J.B. In vivo enhancement of genomic instability in minisatellite sequences of mouse C3H/10T1/2 cells transformed in vitro by X-rays. Cancer Res. 1994, 54:3173-3178.
15. Wilkinson D., Sandhu J.K., Breneman J.W., Tucker J.D., Birnboim H.C. Hprt mutants in a transplantable murine tumour arise more frequently in vivo than in vitro. Br. J. Cancer 1995, 72:1234-1240.
16. Reynolds T.Y., Rockwell S., Glazer P.M. Genetic instability induced by the tumor microenvironment. Cancer Res. 1996, 56:5754-5757.
17. Li C.Y., Little J.B., Hu K., Zhang W., Zhang L., Dewhirst M.W., Huang Q. Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures. Cancer Res. 2001, 61:428-432.
18. Papp-Szabo E., Josephy P.D., Coomber B.L. Microenvironmental influences on mutagenesis in mammary epithelial cells. Int. J. Cancer 2005, 116:679-685.
19. Rice G.C., Hoy C., Schimke R.T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:5978-5982.
20. Young S.D., Marshall R.S., Hill R.P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:9533-9537.
21. Coquelle A., Toledo F., Stern S., Bieth A., Debatisse M. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 1998, 2:259-265.
22. Fischer U., Radermacher J., Mayer J., Mehraein Y., Meese E. Tumor hypoxia: impact on gene amplification in glioblastoma. Int. J. Oncol. 2008, 33:509-515.
23. Coquelle A., Rozier L., Dutrillaux B., Debatisse M. Induction of multiple double-strand breaks within an hsr by meganucleaseI-SceI expression or fragile site activation leads to formation of double minutes and other chromosomal rearrangements. Oncogene 2002, 21:7671-7679.
24. Hammond E.M., Denko N.C., Dorie M.J., Abraham R.T., Giaccia A.J. Hypoxia links ATR and p53 through replication arrest. Mol. Cell. Biol. 2002, 22:1834-1843.
25. Hammond E.M., Dorie M.J., Giaccia A.J. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J. Biol. Chem. 2003, 278:12207-12213.
26. Hammond E.M., Green S.L., Giaccia A.J. Comparison of hypoxia-induced replication arrest with hydroxyurea and aphidicolin-induced arrest. Mutation Res. 2003, 532:205-213.
27. Bencokova Z., Kaufmann M.R., Pires I.M., Lecane P.S., Giaccia A.J., Hammond E.M. ATM activation and signaling under hypoxic conditions. Mol. Cell. Biol. 2009, 29:526-537.
28. Hammond E.M., Dorie M.J., Giaccia A.J. Inhibition of ATR leads to increased sensitivity to hypoxia/reoxygenation. Cancer Res. 2004, 64:6556-6562.
29. Pires I.M., Bencokova Z., Milani M., Folkes L.K., Li J.L., Stratford M.R., Harris A.L., Hammond E.M. Effects of acute versus chronic hypoxia on DNA damage responses and genomic instability. Cancer Res. 2010, 70:925-935.
30. Hammond E.M., Giaccia A.J. The role of ATM and ATR in the cellular response to hypoxia and re-oxygenation. DNA Repair 2004, 3:1117-1122.
31. Smith J., Tho L.M., Xu N., Gillespie D.A. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 2010, 108:73-112.
32. Pires I.M., Bencokova Z., McGurk C., Hammond E.M. Exposure to acute hypoxia induces a transient DNA damage response which includes Chk1 and TLK1. Cell Cycle 2010, 9:2502-2507.
33. Scanlon S.E., Glazer P.M. Hypoxic stress facilitates acute activation and chronic downregulation of fanconi anemia proteins. Mol. Cancer Res.: MCR 2014, 12:1016-1028.
34. Koumenis C., Alarcon R., Hammond E., Sutphin P., Hoffman W., Murphy M., Derr J., Taya Y., Lowe S.W., Kastan M., Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol. Cell. Biol. 2001, 21:1297-1310.
35. Lee J.H., Jin Y., He G., Zeng S.X., Wang Y.V., Wahl G.M., Lu H. Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3gamma inactivation of MDMX protein. J. Biol. Chem. 2012, 287:20898-20903.
36. Freiberg R.A., Hammond E.M., Dorie M.J., Welford S.M., Giaccia A.J. DNA damage during reoxygenation elicits a Chk2-dependent checkpoint response. Mol. Cell. Biol. 2006, 26:1598-1609.
37. Freiberg R.A., Krieg A.J., Giaccia A.J., Hammond E.M. Checking in on hypoxia/reoxygenation. Cell Cycle 2006, 5:1304-1307.
38. Gibson S.L., Bindra R.S., Glazer P.M. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner. Cancer Res. 2005, 65:10734-10741.
39. Gibson S.L., Bindra R.S., Glazer P.M. CHK2-dependent phosphorylation of BRCA1 in hypoxia. Radiat. Res. 2006, 166:646-651.
40. Olcina M.M., Foskolou I.P., Anbalagan S., Senra J.M., Pires I.M., Jiang Y., Ryan A.J., Hammond E.M. Replication stress and chromatin context link ATM activation to a role in DNA replication. Mol. Cell 2013, 52:758-766.
41. Kim B.M., Choi J.Y., Kim Y.J., Woo H.D., Chung H.W. Reoxygenation following hypoxia activates DNA-damage checkpoint signaling pathways that suppress cell-cycle progression in cultured human lymphocytes. FEBS Lett. 2007, 581:3005-3012.
42. Fallone F., Britton S., Nieto L., Salles B., Muller C. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression. Oncogene 2013, 32:4387-4396.
43. Cam H., Easton J.B., High A., Houghton P.J. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1alpha. Mol. Cell 2010, 40:509-520.
44. Kang M.J., Jung S.M., Kim M.J., Bae J.H., Kim H.B., Kim J.Y., Park S.J., Song H.S., Kim D.W., Kang C.D., Kim S.H. DNA-dependent protein kinase is involved in heat shock protein-mediated accumulation of hypoxia-inducible factor-1alpha in hypoxic preconditioned HepG2 cells. FEBS J. 2008, 275:5969-5981.
45. Bouquet F., Ousset M., Biard D., Fallone F., Dauvillier S., Frit P., Salles B., Muller C. A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia. J. Cell Sci. 2011, 124:1943-1951.
46. Kang H.J., Kim H.J., Rih J.K., Mattson T.L., Kim K.W., Cho C.H., Isaacs J.S., Bae I. BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression. J. Biol. Chem. 2006, 281:13047-13056.
47. Economopoulou M., Langer H.F., Celeste A., Orlova V.V., Choi E.Y., Ma M., Vassilopoulos A., Callen E., Deng C., Bassing C.H., Boehm M., Nussenzweig A., Chavakis T. Histone H2AX is integral to hypoxia-driven neovascularization. Nat. Med. 2009, 15:553-558.
48. Wrann S., Kaufmann M.R., Wirthner R., Stiehl D.P., Wenger R.H. HIF mediated and DNA damage independent histone H2AX phosphorylation in chronic hypoxia. Biol. Chem. 2013, 394:519-528.
49. Mihaylova V.T., Bindra R.S., Yuan J., Campisi D., Narayanan L., Jensen R., Giordano F., Johnson R.S., Rockwell S., Glazer P.M. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol. Cell. Biol. 2003, 23:3265-3273.
50. Koshiji M., To K.K., Hammer S., Kumamoto K., Harris A.L., Modrich P., Huang L.E. HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression. Mol. Cell 2005, 17:793-803.
51. Rodriguez-Jimenez F.J., Moreno-Manzano V., Lucas-Dominguez R., Sanchez-Puelles J.M. Hypoxia causes downregulation of mismatch repair system and genomic instability in stem cells. Stem Cells 2008, 26:2052-2062.
52. Bindra R.S., Glazer P.M. Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network. Cancer Lett. 2007, 252:93-103.
53. To K.K., Koshiji M., Hammer S., Huang L.E. Genetic instability: the dark side of the hypoxic response. Cell Cycle 2005, 4:881-882.
54. Nakamura H., Tanimoto K., Hiyama K., Yunokawa M., Kawamoto T., Kato Y., Yoshiga K., Poellinger L., Hiyama E., Nishiyama M. Human mismatch repair gene MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2. Oncogene 2008, 27:4200-4209.
55. Bindra R.S., Schaffer P.J., Meng A., Woo J., Maseide K., Roth M.E., Lizardi P., Hedley D.W., Bristow R.G., Glazer P.M. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol. Cell. Biol. 2004, 24:8504-8518.
56. Bindra R.S., Gibson S.L., Meng A., Westermark U., Jasin M., Pierce A.J., Bristow R.G., Classon M.K., Glazer P.M. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res. 2005, 65:11597-11604.
57. Bindra R.S., Schaffer P.J., Meng A., Woo J., Maseide K., Roth M.E., Lizardi P., Hedley D.W., Bristow R.G., Glazer P.M. Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instability. Ann. N.Y. Acad. Sci. 2005, 1059:184-195.
58. Chan N., Koritzinsky M., Zhao H., Bindra R., Glazer P.M., Powell S., Belmaaza A., Wouters B., Bristow R.G. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res. 2008, 68:605-614.
59. Bindra R.S., Glazer P.M. Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Oncogene 2007, 26:2048-2057.
60. Bindra R.S., Glazer P.M. Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites. Cancer Biol. Ther. 2006, 5:1400-1407.
61. Meng A.X., Jalali F., Cuddihy A., Chan N., Bindra R.S., Glazer P.M., Bristow R.G. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother. Oncol.: J. Eur. Soc. Ther. Radiol. Oncol. 2005, 76:168-176.
62. Fanale D., Bazan V., Caruso S., Castiglia M., Bronte G., Rolfo C., Cicero G., Russo A. Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines. BioMed Res. Int. 2013, 2013:746858.
63. To K.K., Sedelnikova O.A., Samons M., Bonner W.M., Huang L.E. The phosphorylation status of PAS-B distinguishes HIF-1alpha from HIF-2alpha in NBS1 repression. EMBO J. 2006, 25:4784-4794.
64. Yuan J., Narayanan L., Rockwell S., Glazer P.M. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res. 2000, 60:4372-4376.
65. Madan E., Gogna R., Pati U. p53 Ser15 phosphorylation disrupts the p53-RPA70 complex and induces RPA70-mediated DNA repair in hypoxia. Biochem. J. 2012, 443:811-820.
66. Rezvani H.R., Mahfouf W., Ali N., Chemin C., Ged C., Kim A.L., de Verneuil H., Taieb A., Bickers D.R., Mazurier F. Hypoxia-inducible factor-1alpha regulates the expression of nucleotide excision repair proteins in keratinocytes. Nucleic acids Res. 2010, 38:797-809.
67. Liu Y., Bernauer A.M., Yingling C.M., Belinsky S.A. HIF1alpha regulated expression of XPA contributes to cisplatin resistance in lung cancer. Carcinogenesis 2012, 33:1187-1192.
68. Dudas J., Schartinger V.H., Romani A., Schweigl G., Kordsmeyer K., Marta P.I., Url C., Kral F., Riechelmann H. Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer. Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med. 2014.
69. Ito A., Koshikawa N., Mochizuki S., Omura K., Takenaga K. Hypoxia-inducible factor-1 mediates the expression of DNA polymerase iota in human tumor cells. Biochem. Biophys. Res. Commun. 2006, 351:306-311.
70. Ren Y., Hao P., Dutta B., Cheow E.S., Sim K.H., Gan C.S., Lim S.K., Sze S.K. Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies. Mol. Cell. Proteomics: MCP 2013, 12:485-498.
71. Koritzinsky M., Wouters B.G. Hypoxia and regulation of messenger RNA translation. Methods Enzymol. 2007, 435:247-273.
72. Koritzinsky M., Magagnin M.G., van den Beucken T., Seigneuric R., Savelkouls K., Dostie J., Pyronnet S., Kaufman R.J., Weppler S.A., Voncken J.W., Lambin P., Koumenis C., Sonenberg N., Wouters B.G. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J. 2006, 25:1114-1125.
73. Koritzinsky M., Rouschop K.M., van den Beucken T., Magagnin M.G., Savelkouls K., Lambin P., Wouters B.G. Phosphorylation of eIF2alpha is required for mRNA translation inhibition and survival during moderate hypoxia. Radiother. Oncol.: J. Eur. Soc. Ther. Radiol. Oncol. 2007, 83:353-361.
74. Koritzinsky M., Seigneuric R., Magagnin M.G., van den Beucken T., Lambin P., Wouters B.G. The hypoxic proteome is influenced by gene-specific changes in mRNA translation. Radiother. Oncol.: J. Eur. Soc. Ther. Radiol. Oncol. 2005, 76:177-186.
75. Chan N., Ali McCallum M.G.P., Kumareswaran R., Koritzinsky M., Wouters B.G., Wells P.G., Gallinger S., Bristow R.G. Hypoxia provokes base excision repair changes and a repair-deficient, mutator phenotype in colorectal cancer cells. Mol. Cancer Res.: MCR 2014.
76. Pocock R. Invited review: decoding the microRNA response to hypoxia. Pflugers Archiv: Eur. J. Physiol. 2011, 461:307-315.
77. Crosby M.E., Kulshreshtha R., Ivan M., Glazer P.M. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 2009, 69:1221-1229.
78. Valeri N., Gasparini P., Fabbri M., Braconi C., Veronese A., Lovat F., Adair B., Vannini I., Fanini F., Bottoni A., Costinean S., Sandhu S.K., Nuovo G.J., Alder H., Gafa R., Calore F., Ferracin M., Lanza G., Volinia S., Negrini M., McIlhatton M.A., Amadori D., Fishel R., Croce C.M. Modulation of mismatch repair and genomic stability by miR-155. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:6982-6987.
79. Babar I.A., Czochor J., Steinmetz A., Weidhaas J.B., Glazer P.M., Slack F.J. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol. Ther. 2011, 12:908-914.
80. Gee H.E., Camps C., Buffa F.M., Patiar S., Winter S.C., Betts G., Homer J., Corbridge R., Cox G., West C.M., Ragoussis J., Harris A.L. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 2010, 116:2148-2158.
81. Huang X., Le Q.T., Giaccia A.J. MiR-210 - micromanager of the hypoxia pathway. Trends Mol. Med. 2010, 16:230-237.
82. Devlin C., Greco S., Martelli F., Ivan M. miR-210: more than a silent player in hypoxia. IUBMB Life 2011, 63:94-100.
83. Camps C., Buffa F.M., Colella S., Moore J., Sotiriou C., Sheldon H., Harris A.L., Gleadle J.M., Ragoussis J. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2008, 14:1340-1348.
84. Miao F., Bouziane M., Dammann R., Masutani C., Hanaoka F., Pfeifer G. T.R. O'Connor, 3-methyladenine-DNA glycosylase (MPG protein) interacts with human RAD23 proteins. J. Biol. Chem. 2000, 275:28433-28438.
85. Johnson A.B., Denko N., Barton M.C. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutation Res. 2008, 640:174-179.
86. Watson J.A., Watson C.J., McCrohan A.M., Woodfine K., Tosetto M., McDaid J., Gallagher E., Betts D., Baugh J., O'Sullivan J., Murrell A., Watson R.W., McCann A. Generation of an epigenetic signature by chronic hypoxia in prostate cells. Hum. Mol. Genet. 2009, 18:3594-3604.
87. Watson J.A., Watson C.J., McCann A., Baugh J. Epigenetics, the epicenter of the hypoxic response. Epigenet.: Off. J. DNA Methyl. Soc. 2010, 5:293-296.
88. Dutta B., Ren Y., Lim S.K., Tam J.P., Sze S.K. Quantitative profiling of chromatome dynamics reveals a novel role for HP1BP3 in hypoxia-induced oncogenesis. Mol. Cell. Proteomics: MCP 2014.
89. Chen H., Yan Y., Davidson T.L., Shinkai Y., Costa M. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res. 2006, 66:9009-9016.
90. Tausendschon M., Dehne N., Brune B. Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity. Cytokine 2011, 53:256-262.
91. Zhou X., Sun H., Chen H., Zavadil J., Kluz T., Arita A., Costa M. Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase. Cancer Res. 2010, 70:4214-4221.
92. Li Q., Costa M. c-Myc mediates a hypoxia-induced decrease in acetylated histone H4. Biochimie 2009, 91:1307-1310.
93. Shahrzad S., Bertrand K., Minhas K., Coomber B.L. Induction of DNA hypomethylation by tumor hypoxia. Epigenet.: Off. J. DNA Methyl. Soc. 2007, 2:119-125.
94. Lu Y., Wajapeyee N., Turker M.S., Glazer P.M. Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1. Cell Rep. 2014, 8:501-513.
95. Lu Y., Chu A., Turker M.S., Glazer P.M. Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol. Cell. Biol. 2011, 31:3339-3350.
96. Chang C.J., Yang J.Y., Xia W., Chen C.T., Xie X., Chao C.H., Woodward W.A., Hsu J.M., Hortobagyi G.N., Hung M.C. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell 2011, 19:86-100.
97. Shahrzad S., Quayle L., Stone C., Plumb C., Shirasawa S., Rak J.W., Coomber B.L. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression. Cancer Res. 2005, 65:8134-8141.
98. Marotta D., Karar J., Jenkins W.T., Kumanova M., Jenkins K.W., Tobias J.W., Baldwin D., Hatzigeorgiou A., Alexiou P., Evans S.M., Alarcon R., Maity A., Koch C., Koumenis C. In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection. Cancer Res. 2011, 71:779-789.
99. Neumeister V.M., Sullivan C.A., Lindner R., Lezon-Geyda K., Li J., Zavada J., Martel M., Glazer P.M., Tuck D.P., Rimm D.L., Harris L. Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer. Breast Cancer Res. Treat. 2012, 136:67-75.
100. Hammond E.M., Freiberg R.A., Giaccia A.J. The roles of Chk 1 and Chk 2 in hypoxia and reoxygenation. Cancer Lett. 2006, 238:161-167.
101. McNeely S., Beckmann R., Bence Lin A.K. CHEK again: revisiting the development of CHK1 inhibitors for cancer therapy. Pharmacol. Ther. 2014, 142:1-10.
102. Batey M.A., Zhao Y., Kyle S., Richardson C., Slade A., Martin N.M., Lau A., Newell D.R., Curtin N.J. Preclinical evaluation of a novel ATM inhibitor KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer. Mol. Cancer Ther. 2013, 12:959-967.
103. Pires I.M., Olcina M.M., Anbalagan S., Pollard J.R., Reaper P.M., Charlton P.A., McKenna W.G., Hammond E.M. Targeting radiation-resistant hypoxic tumour cells through ATR inhibition. Br. J. Cancer 2012, 107:291-299.
104. Strese S., Fryknas M., Larsson R., Gullbo J. Effects of hypoxia on human cancer cell line chemosensitivity. BMC Cancer 2013, 13:331.
105. Kumareswaran R., Ludkovski O., Meng A., Sykes J., Pintilie M., Bristow R.G. Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability. J. Cell Sci. 2012, 125:189-199.
106. Chan N., Pires I.M., Bencokova Z., Coackley C., Luoto K.R., Bhogal N., Lakshman M., Gottipati P., Oliver F.J., Helleday T., Hammond E.M., Bristow R.G. Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment. Cancer Res. 2010, 70:8045-8054.
107. Liu S.K., Coackley C., Krause M., Jalali F., Chan N., Bristow R.G. A novel poly(ADP-ribose) polymerase inhibitor ABT-888, radiosensitizes malignant human cell lines under hypoxia. Radiother. Oncol.: J. Eur. Soc. Ther. Radiol. Oncol. 2008, 88:258-268.
108. Hegan D.C., Lu Y., Stachelek G.C., Crosby M.E., Bindra R.S., Glazer P.M. Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:2201-2206.
109. Lee J.M., Ledermann J.A., Kohn E.C. PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies. Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol./ESMO 2014, 25:32-40.
110. Dean E., Middleton M.R., Pwint T., Swaisland H., Carmichael J., Goodege-Kunwar P., Ranson M. Phase I study to assess the safety and tolerability of olaparib in combination with bevacizumab in patients with advanced solid tumours. Br. J. Cancer 2012, 106:468-474.
111. Liu J.F., Tolaney S.M., Birrer M., Fleming G.F., Buss M.K., Dahlberg S.E., Lee H., Whalen C., Tyburski K., Winer E., Ivy P., Matulonis U.A. A phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer. Eur. J. Cancer 2013, 49:2972-2978.
112. Hunter F.W., Hsu H.L., Su J., Pullen S.M., Wilson W.R., Wang J. Dual targeting of hypoxia and homologous recombination repair dysfunction in triple-negative breast cancer. Mol. Cancer Ther. 2014.
113. Olcina M., Lecane P.S., Hammond E.M. Targeting hypoxic cells through the DNA damage response. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2010, 16:5624-5629.
114. Wilson W.R., Hay M.P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 11:393-410.